The multidisciplinary breast conference
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Team-based care for a patient diagnosed with breast cancer is critical. The breast cancer disease-based team is composed of physicians from different specialties as well as nurses and other allied health staff. Breast cancer multidisciplinary breast conference (MBC), or tumour boards, allow experts to review a complex case and work together to develop and refine therapeutic strategy. In each case presented, the patient history with clinical, radiological, and pathological findings should be reviewed. Applicable treatment algorithms or care paths should be discussed routinely both before treatment and when full pathology is available to elevate the standard of care. Patients can be given access to clinical trials and important research. The multidisciplinary team (MDT) should meet at a given time (whether physically in one place or by video or teleconferencing) to discuss patients with breast cancer. The presence of an MDT, which meets at least fortnightly, is often a requirement or indicator for audits and accreditation. Breast cancer conferences should be accessible to all MDT members, participation should be tracked on scorecards, and MDT programmes should be accountable.
Fields of Study & Subjects
Interprofessional Education and Collaboration
Breast Cancer Treatment Studies
Breast Lesions and Carcinomas
Publication details
- Journal / source
- Oxford University Press eBooks
- Pages
- 109–122
- Publication date
- 1 March 2026
- Language
- EN
- Document type
- Book chapter